<rt id="yec45"><optgroup id="yec45"></optgroup></rt>

    <rt id="yec45"><nav id="yec45"></nav></rt>
  1. <tt id="yec45"><noscript id="yec45"></noscript></tt>
  2. <rt id="yec45"></rt>
  3. <source id="yec45"><optgroup id="yec45"></optgroup></source>
  4. <cite id="yec45"><form id="yec45"></form></cite>
  5. <tt id="yec45"><noscript id="yec45"></noscript></tt>
    The company just released its inaugural Diversity & Inclusion Impact Review. We take a look inside its pages to see how the company's striving every day to build a culture of belonging.
    It's a common skincare dilemma: You're over the acne stage and wrinkles aren't yet a concern, but you're starting to notice dark spots, fine lines and dull skin. This new line can help address all of it—thanks to the team of millennial scientists behind it.
    It was a shocking diagnosis for the Dallas infant, who was just 2 months old when he contracted the disease. For Child Health Day his mom shares the incredible journey he's been on as a patient—and pint-sized advocate.
    Music stars. World leaders. Activists. They all came together at the Global Citizen Festival to help tackle the world's most pressing issues, including HIV. In the lead-up to the big event, we spoke to some inspiring people playing an active role in fighting the disease—and advocating for those living with it.
    For Prostate Cancer Awareness Month, we sat down with Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer, Janssen Research & Development, to learn more about the latest scientific strides being made in the battle against one of the most common cancers in men.
    The company has appeared on the list for over three decades, and like years past, has nominated a Johnson & Johnson Working Mother of the Year.
    From working to broaden the pool of patients trials have traditionally studied to finding ways for people to participate from the comforts of home, we look at how the company is reinventing clinical trials in truly forward-thinking ways.
    Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.

    Recent Johnson & Johnson Initiatives in the Spotlight

    Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
    This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
    You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.